Interestingly, GCB-DLBCL frequently exhibit deleterious mutations in S1PR2, but also in GNA13 (the gene coding for Gα13), or in the Gα13 effector ARHGEF (103). Here, S1PR2 is linked to diffuse large B-cell lymphoma.